Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United States Antimony (UAMY) Cash & Equivalents (2016 - 2025)

United States Antimony's Cash & Equivalents history spans 16 years, with the latest figure at $30.5 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 67.81% to $30.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $30.5 million, a 67.81% increase, with the full-year FY2025 number at $30.5 million, up 67.81% from a year prior.
  • Cash & Equivalents hit $30.5 million in Q4 2025 for United States Antimony, up from $18.3 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for UAMY hit a ceiling of $30.5 million in Q4 2025 and a floor of $5.8 million in Q2 2025.
  • Historically, Cash & Equivalents has averaged $16.4 million across 5 years, with a median of $16.8 million in 2023.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 100037.01% in 2021 and later tumbled 64.31% in 2022.
  • Tracing UAMY's Cash & Equivalents over 5 years: stood at $21.4 million in 2021, then decreased by 10.75% to $19.1 million in 2022, then plummeted by 37.47% to $12.0 million in 2023, then skyrocketed by 52.01% to $18.2 million in 2024, then surged by 67.81% to $30.5 million in 2025.
  • Business Quant data shows Cash & Equivalents for UAMY at $30.5 million in Q4 2025, $18.3 million in Q3 2025, and $5.8 million in Q2 2025.